Robert "Craig" C. Long, MD
Professor
Department:
SOM-Medicine-CARD
Email:
rlong@umc.edu
Work Phone:
(601) 984-5078
Biography
Dr Long has received a doctor of pharmacy (PharmD) degree from University of Mississippi and a doctor of medicine (MD) degree from University of Mississippi Medical Center. He then completed his training in Internal Medicine and Cardiovascular Diseases at University of Mississippi Medical Center before going to University of Alabama-Birmingham for fellowship in Advanced Heart Failure/Transplant Cardiology and training in Pulmonary Vascular Diseases. He returned to University of Mississippi Medical Center on Faculty and has been a leader in the Advanced Heart Failure/Transplant Cardiology section in helping to grow the Mechanical Circulatory Support Program for which he serves as medical director and the heart transplant program. Due to the need for more physicians specializing in care of heart failure patients, he started the Advanced Heart Failure/Transplant Cardiology fellowship program and has served as the program director since its inception. He has been primary investigator for multiple clinical trials in the heart failure space including both medication and device therapy trials. He is a husband and father of 4 children who enjoys spending time with family supporting his children in their activities and growth. Also enjoy basic woodworking in his free time.
Education
| University of Alabama at Birmingham, MD, Advanced Heart Failure and Transplant Cardiology | 2011 |
| University of Mississippi, MD, Cardiovascular Disease | 2011 |
| University of Mississippi Medical Center, MD, Internal Medicine | 2008 |
| University of Mississippi Medical Center, MD, Internal Medicine | 2006 |
| University of Mississippi, MD, Medicine | 2005 |
| University of Mississippi, PharmD, Pharmacy | 1999 |
| University of Mississippi, BS, Pharmaceutical Sciences | 1997 |
Specialty Certification Licensure
| Licensure, Mississippi Pharmacy License, Mississippi State Board of Pharmacy | 06/1999 - Present |
| Certification, Advanced Heart Failure and Transplant Cardiology, American Board of Internal Medicine | 10/2012 - Present |
| Certification, Internal Medicine, American Board of Internal Medicine | 10/2008 - Present |
| Licensure, Alabama Medical License | 2011 - Present |
| Certification, Cardiovascular Disease, American Board of Internal Medicine | 10/2011 - Present |
| Licensure, Mississippi Medical License | |
| NPI, NPI |
Current Positions
| Fellowship Program Director - Advanced Heart Failure/Transplant Cardiology, School of Medicine, Department of Medicine | 07/2018 - Present |
| Associate Professor, School of Medicine, Department of Medicine | 07/2017 - Present |
| The University of Mississippi Medical Center Jackson, Mississippi 39216 | |
Academic Appointments or Other Previous Appointments
| Assistant Professor, University of Mississippi Medical Center, School of Medicine, Department of Medicine | 2012 - 06/2017 |
Sponsored Program Funding
| Extramural, A Randomized, Open-label Study of Dapagliflozin in Patients with Type 2 Diabetes Admitted with Acute Heart Failure (DICTATE-AHF), Vanderbilt University Medical Center | 01/2020 - Present |
| Extramural, Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68), TIMI Study Group/Brigham and Women’s Hospital | 01/2020 - Present |
| Extramural, A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction ≥ 40% (LVEF ≥ 40%) (FINEARTS), Bayer | 01/2020 - Present |
| Extramural, A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effects of SOtagLiflozin on Clinical Outcomes in HemodynamIcally STable Patients POST Worsening Heart Failure (SOLOIST), Lexicon | 01/2019 - Present |
| Extramural, A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal, Parallel Group Study of Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Medications for the Treatment of Heart Failure DIAMOND (PAT-CR-302), Relypsa | 01/2019 - Present |
| Extramural, A multicentre, randomised, double-blind, 90-day superiority trial to evaluate the effect on clinical benefit, safety and tolerability of once daily oral EMPagliflozin 10 mg compared to placebo, initiated in patients hospitalised for acUte heart faiLure (de novo or decompensated chronic HF) who have been StabilisEd (EMPULSE) 1245-0204, Boehringer Ingelheim | 01/2019 - Present |
| Extramural, A Prospective, Multi-Center, Randomized, Controlled, Single Blind Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class III Heart Failure Patients (PROACTIVE-HF), Endotronics, Inc | 01/2019 - Present |
| Extramural, ALgorithm using LINQ Sensors for EValuatIon And TreatmEnt of Heart Failure (ALLEVIATE-HF), Medtronic, Inc | 01/2019 - Present |
| Extramural, A multicenter, randomized, double-blind, double-dummy, parallel group, active controlled study to evaluate the effect of sacubitril/valsartan (LCZ696) versus valsartan on changes in NT-proBNP and outcomes, safety, and tolerability in HFpEF patients with acute decompensated heart failure (ADHF) who have been stabilized during hospitalization and initiated in-hospital or within 30 days post-discharge. (PARAGLIDE-HF), Novartis | 01/2019 - Present |
| Extramural, A phase III randomised, double-blind trial to evaluate the effect of 12 weeks treatment of once daily EMPagliflozin 10 mg compared with placebo on ExeRcise ability and heart failure symptoms, In patients with chronic HeArt FaiLure with reduced Ejection Fraction (HFrEF) (EMPERIAL-Reduced), Boehringer Ingelheim | 01/2018 - 01/2020 |
| Extramural, A phase III randomised, double-blind trial to evaluate the effect of 12 weeks treatment of once daily EMPagliflozin 10 mg compared with placebo on ExeRcise ability and heart failure symptoms, In patients with chronic HeArt FaiLure with preserved Ejection Fraction (HFpEF) (EMPERIAL – Preserved), Boehringer Ingelheim | 01/2018 - 01/2020 |
| Extramural, A randomized parallel-group, placebo-controlled, double-blind, multi-center trial to eValuate the effIcacy and safeTy of the orAL sGC stImulator vericiguaT to improve phYsical functioning in activities of daily living in patients with heart failure and preserved ejection fraction (VITALITY-HFpEF), Bayer | 01/2018 - 08/2019 |
| Extramural, ToRsemide compArisoN with furoSemide FOR Management of Heart Failure (Transform-HF, Duke Clinical Resarch Institute), Duke Clinical Research Institute | 01/2018 - Present |
| Extramural, ANTHEM-HFrEF: Autonomic Retulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure with Reduced Ejection Fraction, LivaNova | 01/2018 - Present |
| Extramural, PANTHEON- A multicenter, randomized, placebo-controlled, parallel group, double blind, dose-finding Phase II trial to study the efficacy, safety, pharmacokinetic and pharmacodynamic effects of the oral partial adenosine A1 receptor agonist neladenoson bialanate over 20 weeks in patients with chronic heart failure with reduced ejection fraction., Bayer | 07/2017 - 01/2019 |
| Extramural, INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure (INVESTED), Partners Healthcare | 01/2017 - 11/2019 |
| Extramural, Comparison of Saocubitril/valsartaN Versus Enalapril on Effect on ntpRo-bnp in Patients Stabilized From an Acute Heart Failure Episode (PIONEER-HF), Novartis Pharmaceuticals | 01/2017 - 02/2019 |
| Extramural, VICTORIA: A randomized parallel-group, placebo-controlled, double-blind, event-driven, multi-center pivotal Phase III clinical outcome trial of efficacy and safety of the oral sGC stimulator vericiguat in subjects with heart failure with reduced ejection fraction (HFrEF)- VerICiguaT Global Study in Subjects with Heart Failure with Reduced Ejection Fraction, Merck | 07/2016 - 01/2020 |
| Intramural, Bariatric Surgery and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction | 06/2016 - 12/2019 |
| Extramural, Dilated Cardiomyopathy Research Project, The Ohio State University | 04/2016 - Present |
| Extramural, INTERVENE-HF: Integrated Diagnostics Driven Diuretic and Chronic Medication Management for Heart Failure, Medtronic, Inc | 01/2016 - 01/2019 |
| Extramural, BEAT-HF. Barostim neo- Baroreflex Activation Therapy for Heart Failure, CVRx, Inc | 08/2015 - Present |
| Extramural, PARAGON-HF. A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to valsartan, on morbidity and mortality in heart failure patients (NYHA Class II-IV) with preserved ejection fraction, Novartis | 07/2015 - 09/2019 |
| Extramural, COUNTER HF. C-Pulse Heart Device pivOtal stUdy treatiNg paTients With modERate to Severe Heart Failure C-Pulse System: A Heart Assist Device Pivotal IDE Study, Sunshine Heart | 03/2015 - 07/2017 |
| Extramural, FINESSE-HF, Bayer | 01/2015 - 12/2016 |
| Extramural, An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects with Portal Hypertension, Conatus Pharmaceuticals Inc | 12/2014 - 12/2017 |
| Extramural, SOCRATES-PRESERVED. A randomized parallel-group, placebo-controlled, double blind, multicenter dose finding phase II trial exploring the pharmacodynamics effects, safety and tolerability and pharmacokinetics of four dose regimens of the oral sGC stimulator vericiguat over 12 weeks in patients with worsening heart failure and preserved ejection fraction., Bayer | 05/2014 - 09/2015 |
| Extramural, SOCRATES-REDUCED. A randomized parallel-group, placebo-controlled, double blind, multicenter dose finding phase II trial exploring the pharmacodynamics effects, safety and tolerability and pharmacokinetics of four dose regimens of the oral sGC stimulator vericiguat over 12 weeks in patients with worsening heart failure and reduced ejection fraction., Bayer | 05/2014 - 06/2015 |
| Extramural, RLX030A. A multicenter, randomized, double blind, placebo controlled phase IIIb study to evaluate the efficacy, safety and tolerability of Serelaxin when added to standard therapy in acute heart failure patients, Novartis | 03/2014 - 12/2018 |
| Extramural, A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects with Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH), Gilead Sciences | 02/2014 - 12/2018 |
| Extramural, Barostim HOPE4HF Study. Prospective, Randomized Study Describing the Safety and Efficacy of the Neo System in Approximately 60 Heart Failure Subjects with a Left Ventricular Ejection Fraction Equal to or Less than 35 Percent, CVRx, Inc. | 12/2013 - Present |
| Extramural, Phase III, Multicenter, Randomized,Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ularitide (Urodilatin) Intravenous Infusion in Patients Suffering from Acute Decompensated Heart Failure [True-AHF], Cardiorentis | 02/2013 - 12/2013 |
| Extramural, A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome (ACS) Subjects with Unstable Angina/Non-ST-Elevation Myocardial Infarction (UA/NSTEMI) Who are Medically Managed - The TRILOGY ACS Study, Eli Lilly and Company | 08/2008 - 05/2009 |
| Extramural, A Phase III, Double-Blind, Randomized Placebo-Controlled Study to Evaluate the Effects of RO4607381 on Cardiovascular (CV) Risk in Stable CHD Patients with Documented Recent Acute Coronary Syndrome (ACS), Hoffman-La Roche | 06/2008 - 12/2008 |
Publications
Letter | |
| Hall ME, Vaduganathan M, Khan MS, Papadimitriou L, Long RC, Hernandez GA, Moore CK, Lennep BW, McMullan MR, Butler J, Reductions in Heart Failure Hospitalizations During the COVID-19 Pandemic. Journal of cardiac failure, 2020 Jun;26(6):462-463 | 2020 |
Review | |
| Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Hall ME, Yanes L, Long RC, Koch CA, Hormones of the Cardiovascular System. , 2000; | |
Journal Article | |
| Lam CSP, Giczewska A, Sliwa K, Edelmann F, Refsgaard J, Bocchi E, Ezekowitz JA, Hernandez AF, O'Connor CM, Roessig L, Patel MJ, Pieske B, Anstrom KJ, Armstrong PW, VICTORIA Study Group, Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial. JAMA cardiology, 2021 Jun 1;6(6):706-712 | 2021 |
| Morales A, Kinnamon DD, Jordan E, Platt J, Vatta M, Dorschner MO, Starkey CA, Mead JO, Ai T, Burke W, Gastier-Foster J, Jarvik GP, Rehm HL, Nickerson DA, Hershberger RE, DCM Precision Medicine study of the DCM Consortium, DCM Consortium institutions and personnel participating in this study: Study Principal Investigator and Co-Investigators,DCM Consortium Clinical Site Principal Investigators and Clinical Site Other Significant Contributors (OSC). The following clinical sites and individuals contributed to the submission of RO 1 H L 128857 as Site Principal Investigators (Site Pl) or as Other Significant Contributors (OSC),Dr. Huggins also served as study co-principal investigator,The following clinical site was added following approval of NHGRI supplemental funding but prior to initiation of enrollment,The following clinical sites were added following study activation, Variant Interpretation for Dilated Cardiomyopathy: Refinement of the American College of Medical Genetics and Genomics/ClinGen Guidelines for the DCM Precision Medicine Study. Circulation. Genomic and precision medicine, 2020 Apr;13(2):e002480 | 2020 |
| Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, Lam CSP, Ponikowski P, Voors AA, Jia G, McNulty SE, Patel MJ, Roessig L, Koglin J, O'Connor CM, VICTORIA Study Group, Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. The New England journal of medicine, 2020 May 14;382(20):1883-1893 | 2020 |
| Papadimitriou L, Moore CK, Butler J, Long RC, The Limitations of Symptom-based Heart Failure Management. Cardiac failure review, 2019 May;5(2):74-77 | 2019 |
| Hall ME, Halinski JA, Skelton TN, Campbell WF, McMullan MR, Long RC, Alexander MN, Pollard JD, Hall JE, Fox ER, Winniford MD, Kamimura D, Left Ventricular False Tendons are Associated With Left Ventricular Dilation and Impaired Systolic and Diastolic Function. The American journal of the medical sciences, 2017 Sep;354(3):278-284 | 2017 |
| Beard WL, Long RC, Geraci SA, Palliative care for the terminal heart failure patient. Journal of the Mississippi State Medical Association, 2014 Jan;55(1):4-10 | 2014 |
| Minor DS, Meyer AM, Long RC, Butler KR Jr, β-Blockers and chronic obstructive pulmonary disease: inappropriate avoidance? Journal of clinical hypertension (Greenwich, Conn.), 2013 Dec;15(12):925-30 | 2013 |
| Nickens MA, Long RC, Geraci SA, Cardiovascular disease in pregnancy: (women's health series). Southern medical journal, 2013 Nov;106(11):624-30 | 2013 |
| Long RC, Wofford MR, Harkins KG, Minor DS, Hepatocellular necrosis associated with labetalol. Journal of clinical hypertension (Greenwich, Conn.), 2007 Apr;9(4):287-90 | 2007 |
Review Article | |
| Hall ME, Yanes LL, Long RC, Koch CA Hormones of the Cardiovascular System www.thyroidmanager.org | 2015 |
Abstracts | |
| S Kancharla, AA Oshunbade, RC Long, G Hernandez, B Lennep, L Papadimitriou, C Moore, J Butler, ME Hall. Effects of sex and race on guideline directed medical therapy for heart failure with reduced ejection fraction. JOURNAL OF INVESTIGATIVE MEDICINE 69 (2), 495-495. | 2021 |
| Lennep B, Long RC, Hall ME, Guild. Septic Diffuse Left Ventricular Calcification. Journal of Investigative Medicine. 2018; 66:371-372. | 2018 |
| Hall ME, Halinski JA, Skelton TN, Campbell WF, McMullan MR, Long RC, Alexander MN, Pollard JD, Hall JE, Fox ER, Winniford MD, Kamimura D. Left Ventricular False Tendons are Associated With Left Ventricular Dilation and Impaired Systolic and Diastolic Function. Am J Med Sci. 2017 Sep;354(3):278-284 | 2017 |
Presentations
| State/Local Invited Seminars/Lectures, Pulmonary HTN Part Deux - Treatment, University of Mississippi Medical Center, Cardiology Fellows Conference | 03/2021 |
| State/Local Invited Seminars/Lectures, Transplant/Heart Failure Series, University of Mississippi Medical Center, Cardiology Fellows Conference | 02/2021 |
| State/Local Invited Seminars/Lectures, History of Heart Transplantation, University of Mississippi Medical Center, Cardiology Noon Conference | 10/2020 |
| Regional Invited Seminars/Lectures, Cardio-Oncology, Gulf Coast Oncology Summit, Gulf Coast Oncology Summit - Virtual Meeting | 04/2020 |
| State/Local Invited Seminars/Lectures, Stories of Hope for Heart Failure, Mississippi Transplant Association, Mississippi Transplant Forum; Jackson, MS | 10/2019 |
| State/Local Invited Seminars/Lectures, Heart Failure: Optimizing Guideline Directed Medical Therapy in 2019, University of Mississippi Medical Center, Cardiovascular Disease Symposium for the Primary Care Provider; Jackson, MS | 04/2019 |
| State/Local Invited Seminars/Lectures, Heart Failure: Optimizing Guideline Directed Medical Therapy, University of Mississippi Medical Center, Cardiology Noon Conference | 04/2019 |
| Regional Invited Seminars/Lectures, End-Stage heart Disease: What are the Options?, New Cardiovascular Horizons Mid-South, Advancements in Care of the CV Patient: Multidisciplinary Strategies for Optimal Results Conference; Jackson, MS | 12/2018 |
| State/Local Invited Seminars/Lectures, Heart Failure: Management Update, Grenada Lake Medical Center; Grenada, MS, Grand Rounds- Grenada Lake Medical Center | 09/2018 |
| State/Local Invited Seminars/Lectures, Advanced Heart Failure, University of Mississippi Medical Center, Cardiology Noon Conference | 05/2018 |
| Regional Invited Seminars/Lectures, Burden of Heart Failure on our Community, American Heart Association Go Red for Women Event, AHA Improving Women's Cardiovascular Health for a Healthier Mississippi Conference | 05/2018 |
| State/Local Invited Seminars/Lectures, Pulmonary Hypertension, University of Mississippi Medical Center, UMMC - Department of Medicine Grand Rounds | 01/2018 |
| Regional Invited Seminars/Lectures, Update on Heart Failure, American College of Physicians, Mississippi/Alabama ACP Annual Meeting | 06/2017 |
| State/Local Invited Seminars/Lectures, Advanced Therapies: Partnering with Primary Care Providers to Manage End-Stage Heart Failure, Cardiovascular Symposium for the Primary Care Provider - UMMC, Jackson, MS | 04/2017 |
| State/Local Invited Seminars/Lectures, Heart Failure-Reducing Readmissions, UMMC-Grenada, Grand Rounds. | 02/2017 |
| Oral Presentation, Septic Diffuse Left Ventricular Calcification - Lennep BW, Long RC, Hall ME, Guild CS - Oral presentation., Southern Society for Clinical Investigation, Southern Regional Meeting; New Orleans, LA | 02/2017 |
| State/Local Invited Seminars/Lectures, Breakfast in Red: The Issue, American Heart Association, Jackson, MS | 09/2016 |
| State/Local Invited Seminars/Lectures, Advanced Heart Failure Therapies: Patient Selection for Heart Transplantation, Cardiology Noon Educational Conference, UMMC | 07/2016 |
| State/Local Invited Seminars/Lectures, Update on LVAD Therapy, Cardiology Noon Educational Conference, Jackson, MS | 06/2016 |
| State/Local Invited Seminars/Lectures, Transplantation, What a Primary Care Physician Needs to Know, Department of Medicine, Jackson, MS | 02/2016 |
| State/Local Invited Seminars/Lectures, Overview of Advanced Heart Failure Treatment, Mississippi Transplant Forum, Jackson, MS | 10/2015 |
| State/Local Invited Seminars/Lectures, What’s New in Heart Failure, Mississippi Pharmacists Association Consultant Seminar, Jackson, MS | 09/2015 |
| State/Local Invited Seminars/Lectures, Pulmonary Hypertension: Recognizing an Often Silent Killer, Department of Medicine, Jackson, MS | 06/2015 |
| Regional Invited Seminars/Lectures, Percutaneous Aortic Valve Closure in an LVAD Patient, 2015 HeartWare Southeast Experts Forum, Raleigh, NC | 03/2015 |
| State/Local Invited Seminars/Lectures, Heart Failure Primer for the Home Health Nurse 201: Advanced Heart Failure Therapies, Sta-Home Health Agency, Jackson, MS | 03/2015 |
| State/Local Invited Seminars/Lectures, Heart Failure Therapies: What's on the Horizon, Cardiology Noon Educational Conference, UMMC | 09/2014 |
| State/Local Invited Seminars/Lectures, Primary Care for the Heart Transplant Patient: Pitfalls and Pearls, Mississippi Transplant Forum, Jackson, MS | 08/2014 |
| State/Local Invited Seminars/Lectures, What you need to Know about an LVAD Patient in Your Office, Mississippi Transplant Forum, Jackson, MS | 08/2014 |
| State/Local Invited Seminars/Lectures, Heart Failure: What the Internist Needs to Know, Internal Medicine Resident Educational Conference, Jackson, MS | 04/2014 |
| State/Local Invited Seminars/Lectures, Who to refer for Advanced Heart Failure Evaluation, Cardiology Noon Educational Conference, Jackson, MS | 03/2014 |
| State/Local Invited Seminars/Lectures, Pulmonary Hypertension for Primary Care Provider, Grenada Lake Medical Center, Grenada, MS | 02/2014 |
| State/Local Invited Seminars/Lectures, When Family Involvement Impedes Healthcare, Schwartz Center Rounds, Jackson, MS | 12/2013 |
| National and International Invited Seminars/Lectures, Pulmonary Hypertension for the Family Medicine Specialist, Edna G. Kynett Seminar Series, Department of Family and Community Medicine, Jefferson Medical College, Philadelphia, PA | 12/2013 |
| State/Local Invited Seminars/Lectures, Cardiac Signs and Symptoms: Focus on Heart Failure, Introduction to Clinical Medicine Medical Student Lecture, Jackson, MS | 11/2013 |
| State/Local Invited Seminars/Lectures, Advanced Heart Failure Therapies: Patient Selection for Heart Transplantation, Cardiology Noon Educational Conference, Jackson, MS | 08/2013 |
| Regional Invited Seminars/Lectures, Heart Failure Therapies- Through the Stages, Pioneer Health Services Physicians Educational Symposium, Destin, FL | 07/2013 |
| State/Local Invited Seminars/Lectures, Heart Transplantation- The Basics, Grenada Lake Medical Center, Grenada, MS | 07/2013 |
| State/Local Invited Seminars/Lectures, Pulmonary Hypertension, Southern Association of Cardiovascular and Pulmonary Rehabilitation Spring Regional Conference, Jackson, MS | 04/2013 |
| State/Local Invited Seminars/Lectures, Heart Failure Therapies, Family Medicine Update, Jackson, MS | 04/2013 |
| Mississippi Public Broadcasting Think Radio’s Southern Remedy Panel, Focus on Heart Disease in Women, Mississippi Public Broadcasting, Jackson, MS | 04/2013 |
| State/Local Invited Seminars/Lectures, History of Heart Transplantation, UMMC Cardiology Noon Conference, Jackson, MS | 01/2013 |
| State/Local Invited Seminars/Lectures, Heart Failure- Management and Treatment, Mississippi Pharmacists Association, Jackson, MS | 09/2012 |
| State/Local Invited Seminars/Lectures, Advanced Heart Failure Therapies, Department of Medicine, Jackson, MS | 05/2012 |
| State/Local Invited Seminars/Lectures, Pulmonary Hypertension for the Primary Care Provider, Cardiovascular Disease and Stroke Symposium for the Primary Care Provider, Jackson, MS | 03/2012 |
| State/Local Invited Seminars/Lectures, Defibrillator Lead Malfunction after Left Ventricular Assist Device Placement, Mississippi Chapter of American College of Physicians 17th Annual Associates Competition, Jackson, MS | 10/2010 |
| State/Local Invited Seminars/Lectures, Necrotizing Pneumonia caused by Methicillin-resistant Staphylococcus aureus carrying the Panton Valentine Leukocidin Gene, Mississippi Chapter of American College of Physicians 13th Annual Associates Competition, Jackson, MS | 11/2006 |
| Poster Presentation, Hepatocellular Necrosis Associated with Labetalol, American Society of Hypertension Twentieth Annual Scientific Meeting, San Franciso, CA | 05/2005 |
| State/Local Invited Seminars/Lectures, Angiotensin Converting Enzyme Inhibitors, A Class Review and Use in the Mississippi Medicaid Population, Mississippi Division of Medicaid, Regional Drug Utilization Review Board Meetings, Oxford, MS | 08/1998 |
| Regional Invited Seminars/Lectures, Angiotensin Converting Enzyme Inhibitors, A Class Review and Use in the Mississippi Medicaid Population, Mississippi Division of Medicaid, Regional Drug Utilization Review Board, Jackson, MS | 08/1998 |
| State/Local Invited Seminars/Lectures, Angiotensin Converting Enzyme Inhibitors, A Class Review and Use in the Mississippi Medicaid Population, Mississippi Division of Medicaid, Regional Drug Utilization Review Board, Hattiesburg, MS | 08/1998 |
Honors, Awards, and Recognition
| Robert J. Snavely Memorial Award, University of Mississippi | 2005 |
| Amsouth Bank Scholarship, Amsouth Bank | 2005 |
| Phi Kappa Phi, Phi Kappa Phi | 2005 |
| Alpha Omega Alpha, Alpha Omega Alpha | 2005 |
Professional Membership and Service
| Heart Failure Society of America, Member | 2011 - Present |
| International Society of Heart and Lung Transplantation, Member | 2011 - Present |
| American College of Cardiology, Member | 2008 - Present |
Committee Service
| MEDICAL CENTER-FACULTY SENATE, Member | 2020 - Present |
| THE UNIVERSITY HOSPITALS AND CLINICS-PHARMACY AND THERAPEUTICS, Chair | 2016 - Present |
| Antibiotic Stewardship Committee, Member | 2016 - Present |
| MEDICAL CENTER-FACULTY SENATE, Member | 2015 - Present |
| Cardiology Fellowship Clinical Competency Committee, Member | 2014 - Present |
| THE UNIVERSITY HOSPITALS AND CLINICS-PHARMACY AND THERAPEUTICS, Formulary Subcommittee Member | 2013 - Present |
| THE UNIVERSITY HOSPITALS AND CLINICS-PHARMACY AND THERAPEUTICS, Member | 2013 - Present |
| Region 3 United Network for Organ Sharing (UNOS) Heart Review Board, Member | 2013 - Present |
| Hospital Readmissions Prevention Committee, Member | 2012 - 2014 |
| Lifesavers Committee MORA/UMMC Collaborative Committee, Member | 2012 - Present |
Community Service
| Talks to local elementary school students, Speaker about benefits of healthy eating/exercise and avoiding tobacco products | 03/2016 - 03/2016 |
| MadCAAP (Madison Countians Allied Against Poverty), Organized Group Donation of Christmas Presents | 12/2014 - 12/2015 |
| Bellwether Church, Member | 2012 - Present |
| MS Blood Services, Regular blood donor | 2012 - Present |
Other Service
| Journal of Clinical and Translational Endocrinology | 03/2015 - Present |
| Southern Medical Journal | 07/2013 - Present |
Teaching Experience
| Medicine, Lecture, Guest Presenter, Advanced Heart Failure: Multidisciplinary Therapy 2012 | Spring 2012 |
| Medicine, Course, Course Presenter, Family Medicine Update 2012 | Spring 2012 |
Fellows supervised
| Cardiovascular Diseases, Training Faculty, 15 fellows supervised | 07/2021 - 06/2022 |
| Advanced Heart Failure/Transplant Cardiology, Program Director, 1 fellows supervised | 07/2020 - 06/2021 |
| Cardiovascular Diseases, Training Faculty, 15 fellows supervised | 07/2020 - 06/2021 |
| Advanced Heart Failure/Transplant Cardiology, Program Director, 1 fellows supervised | 07/2019 - 06/2020 |
| Cardiovascular Diseases, Training Faculty, 15 fellows supervised | 07/2019 - 06/2020 |
| Advanced Heart Failure/Transplant Cardiology, Program Director, 1 fellows supervised | 07/2018 - 06/2019 |
| Cardiovascular Diseases, Training Faculty, 15 fellows supervised | 07/2018 - 06/2019 |
| Cardiovascular Diseases, Training Faculty, 14 fellows supervised | 07/2017 - 06/2018 |
| Cardiovascular Diseases, Training Faculty, 14 fellows supervised | 07/2016 - 06/2017 |
| Cardiovascular Diseases, Attending Physician, 13 fellows supervised, Cardiac catheterization lab and Advanced Heart Failure Rotations | 07/2015 - 06/2016 |
| Cardiovascular Diseases, Attending Physician, 13 fellows supervised, Cardiac catheterization lab and Advanced Heart Failure Rotations | 07/2014 - 06/2015 |
| Cardiovascular Diseases, Research Advisor, 1 fellows supervised | 07/2014 - 06/2015 |
| Cardiovascular Diseases, Attending Physician, 14 fellows supervised, Cardiac catheterization lab and Advanced Heart Failure Rotations | 07/2013 - 06/2014 |
| Cardiovascular Diseases, Mentor, 1 fellows supervised | 07/2013 - 06/2016 |
| Cardiovascular Diseases, Attending Physician, 14 fellows supervised, Cardiac catheterization lab and Advanced Heart Failure Rotations | 07/2012 - 06/2013 |
| Cardiovascular Diseases, Attending Physician, 13 fellows supervised, Cardiac catheterization lab and Advanced Heart Failure Rotations | 01/2012 - 06/2012 |